J&J quarterly sales rise 4.2 percent

(Reuters) - Johnson & Johnson reported a 4.2 percent increase in quarterly revenue, fueled by strong sales in its prescription drugs business.

J&J quarterly sales rise 4.2 percent
Read More


Bagikan Berita Ini